Table 2 |
||
|
Antihistamines commonly used and indicated for the treatment of urticaria. |
||
|
Usual adult dose |
Usual pediatric dose |
|
|
|
||
|
Second-generation H1-receptor antihistamines (first-line therapy) |
||
|
|
||
|
Cetirizine (Reactine) |
10-40 mg daily |
5-10 mL (1-2 teaspoons) daily (children’s formulation) |
|
Desloratadine (Aerius) |
5-20 mg daily |
2.5-5 mL (0.5-1.0 teaspoon) daily (children’s formulation) |
|
Fexofenadine (Allegra) |
120-480 mg daily |
Not currently indicated for children under 12 years of age |
|
Loratadine (Claritin) |
10-40 mg daily |
5-10 mL (1-2 teaspoons) daily (children’s formulation) |
|
|
||
|
First-generation H1-receptor antihistamines (best used as adjunctive therapy for patients with nocturnal symptoms) |
||
|
|
||
|
Hydroxyzine (Atarax) |
25-50 mg, three to four times daily |
Children < 6 years: 30 to 100 mg daily in divided doses |
|
Diphenhydramine (Benadryl) |
25-50 mg, every -6 hours |
2.5-20 mL (0.5-4 teaspoons) every 4 to 6 hours (depending on age/weight) |
|
Cyproheptadine (Periactin) |
4-20 mg daily |
2-4 mg, two to three times daily (depending on age/weight) |
|
Chlorpheniramine (Chor-Tripolon) |
4 mg every 4–6 hours |
1 mg every 4–6 hours |
|
Clemastine (Tavist-1) |
1.34 - 2.68 mg, two to three times daily |
1.34 mg, once or twice daily |
|
|
||
|
Kanani et al. Allergy, Asthma & Clinical Immunology 2011 7(Suppl 1):S9 doi:10.1186/1710-1492-7-S1-S9 |
||